duloxetine hydrochloride has been researched along with Pain, Chronic in 68 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 44 (64.71) | 24.3611 |
| 2020's | 24 (35.29) | 2.80 |
| Authors | Studies |
|---|---|
| Bierma-Zeinstra, SMA; Bindels, PJE; Koffeman, AR; Koopmanschap, MA; Schiphof, D; van den Driest, JJ | 1 |
| Blikman, T; Bulstra, SK; Dijkstra, B; Rienstra, W; Stevens, M; Ten Hagen, AJ; van den Akker-Scheek, I; van Raaij, TM; Zijlstra, WP | 1 |
| Ammitzbøll, N; Arendt-Nielsen, L; Bertoli, D; Brock, C; Drewes, AM; Olesen, AE; Petersen, KK | 1 |
| Clark, JD; Irvine, KA; Sahbaie, P; Shi, XY | 1 |
| Koyama, K | 1 |
| Alcántara Montero, A; Pacheco de Vasconcelos, SR | 1 |
| Beaudoin, FL; DeLomba, WC; Gaither, R; McLean, SA | 1 |
| Banner, E; Brummett, CM; Clauw, DJ; Cole, C; Favorite, T; Fisher, L; Golmirzaie, GM; Harris, RE; Harte, SE; Hassett, AL; Ichesco, E; Kaplan, CM; Kidwell, KM; King, A; Kohns, DJ; Kratz, AL; Lobo, R; Mawla, I; McAfee, J; Murphy, SL; Schneiderhan, JR; Schrepf, A; Scott, KA; Shaikh, S; Tsodikov, A; Wasserman, RA; Williams, DA | 1 |
| Dang, L; Vandal, C; Winslow, BT | 1 |
| Nodera, H | 1 |
| Chung, CP; Corriere, MA; Daniel, LL; Dickson, AL; Dupont, WD; Hall, K; Murray, KT; Nepal, P; Plummer, WD; Ray, WA; Stein, CM | 1 |
| Birkinshaw, H; Cole, P; Eccleston, C; Friedrich, CM; Moore, RA; Phillippo, D; Pincus, T; Serfaty, M; Stewart, G; White, S | 1 |
| Guo, Y; Li, G; Ma, X; Sun, J; Sun, W; Wang, L; Zhou, S | 1 |
| Chen, H; He, Y; Li, J; Li, L; Su, H; Su, S; Wang, T; Yang, P | 1 |
| Flynn, D | 1 |
| Alev, L; Cheng, YY; Enomoto, H; Fujikoshi, S; Skljarevski, V; Wang, J; Yue, L | 1 |
| Ariyoshi, K; Hasegawa, Y; Hasuo, H; Ishiki, H; Iwase, S; Kataoka, Y; Kawaguchi, T; Koyama, A; Matsuda, Y; Matsumoto, Y; Matsuoka, H; Miyaji, T; Morita, T; Nakura, M; Ohtake, Y; Otani, H; Otsuka, M; Oyamada, S; Sakai, K; Sakuma, H; Satomi, E; Tahara, K; Tokoro, A; Tsukuura, H; Yamaguchi, T | 1 |
| Liu, Z; Lu, W; Wang, Q; Weng, C; Xu, J | 1 |
| Asaki, T; Fujita, M; Kasai, E; Matsuo, M; Sakurai, Y; Tamano, R; Yoneda, S | 1 |
| Clark, JD; Ferguson, AR; Irvine, KA; Sahbaie, P | 1 |
| Kimura, M; Onda, A | 1 |
| Badgaiyan, RD; Gupta, K; Jarrett, S; Palzer, EF; Sagi, V; Tran, H | 1 |
| Ishida, M; Itoh, N; Konno, S; Ochiai, T; Tsuji, T; Uchio, Y | 1 |
| Navratilova, E; Phelps, CE; Porreca, F | 1 |
| Auer, DP; Bailey, H; Cottam, WJ; Knaggs, RD; Mahajan, RP; Reckziegel, D; Tench, CR; Walsh, DA | 1 |
| Bierma-Zeinstra, SMA; Bindels, PJE; Koffeman, AR; Koopmanschap, MA; Luijsterburg, PAJ; Schiphof, D; van den Driest, JJ | 1 |
| Murai, N; Naito, M; Nakano, T; Ohmichi, M; Ohmichi, Y; Oshibuchi, H; Sato, J; Takeshita, N; Yasui, M | 1 |
| DiMarzio, M; Gillogly, M; Pilitsis, JG; Prabhala, T; Prusik, J; Sabourin, S | 1 |
| Enomoto, T; Hasegawa, R; Hori, N; Inada, E; Isek, M; Katsuta, Y; Koh, K; Saito, R; Sugasawa, Y; Sugita, M; Takahashi, Y; Yamaguchi, K | 1 |
| Beaudoin, FL; McLean, SA; Santhanam, DR; Strauss, DH | 1 |
| Alev, L; Enomoto, H; Konno, SI; Ochiai, T; Oda, N | 1 |
| Bidari, A; Ghavidel-Parsa, B; Hassankhani, A; Hosseini, S; Moazen-Zadeh, E; Rahmani, S | 1 |
| Bi, L; Chen, J; Dueñas, H; He, D; Li, X; Li, Z; Skljarevski, V; Wang, CN; Wang, G; Wu, T; Yue, L; Zhao, D | 1 |
| Alaka, K; Arnold, LM; Mehta, R; Qiao, M; Upadhyaya, HP; Williams, D | 1 |
| Buhidma, Y; Duty, S; Leta, V; Malcangio, M; Ray Chaudhuri, K; Rukavina, K; Sportelli, C | 1 |
| Gaynor, PJ; Liu, P; Weller, MA; Wohlreich, MM | 1 |
| Andrews, JS; Bansal, M; Happich, M; Klein, RW; Wielage, RC | 1 |
| Cawston, H; Davie, A; Happich, M; Paget, MA; Skljarevski, V | 1 |
| Beekman, AT; Bet, PM; de Heer, EW; Dekker, J; Hakkaart-Van Roijen, L; Holwerda, TJ; Kat, F; Ringoir, L; Roth, J; van der Feltz-Cornelis, CM; van Eck van der Sluijs, JF; van Marwijk, HW | 1 |
| Cai, N; Moore, RA; Skljarevski, V; Tölle, TR | 1 |
| Itoh, M; Masuda, R; Suzuki, T | 1 |
| Bhatnagar, A; Billeter, AT; Hellmann, JL; Polk, HC | 1 |
| Hughes, RA; Lunn, MP; Wiffen, PJ | 1 |
| Ahl, J; Margherita, A; Ruff, DD; Sagman, D; Schroer, M; Williamson, OD; Wohlreich, MM | 1 |
| Engel, CC | 1 |
| Breivik, H | 1 |
| Aoki, T; Fushiki, H; Honda, S; Irie, M; Iwashita, A; Murai, N; Murakami, Y; Nagakura, Y; Tamura, S | 1 |
| Asaki, T; Hasegawa, M; Ishida, M; Shinohara, S; Tamano, R | 1 |
| Bhatia, A | 1 |
| Taylor, BK; Westlund, KN | 1 |
| Alev, L; Konno, S; Ochiai, T; Oda, N | 1 |
| Bi, L; Chen, J; Dueñas, H; He, D; Li, X; Li, Z; Skljarevski, V; Wang, CN; Wang, G; Yue, L; Zhao, D | 1 |
| Alvarenga, R; Manhães, A; Schmidt, G; Schmidt, S | 1 |
| Cutler, N | 1 |
| Alcantara-Montero, A | 1 |
| Dong, D; Ji, Z; Li, H; Yan, S; Zhang, M | 1 |
| Granger, RE; Hussain, N; Lee, AC; Lee, MS; Li, H; McIntosh, D; Raskin, J; Ruschel, S; Sagman, D | 1 |
| Banerjee, M; Griggs, JJ; Hayes, DF; Henry, NL; Schott, AF; Smerage, JB; Van Poznak, C; Wicha, M | 1 |
| Liu, J; Shi, L; Zhao, Y | 1 |
| Patel, TA; Rastogi, R; Swarm, RA | 1 |
| Hegerl, U; Hundemer, HP; Linden, M; Mergl, R; Quail, D; Schneider, E | 1 |
| Dundon, K; Mease, PJ; Sarzi-Puttini, P | 1 |
| Rizzi, M; Sarzi-Puttini, P; Spaeth, M | 1 |
| Gaynor, P; Hanna, S; Hochberg, MC; Risser, R; Wohlreich, M | 1 |
| Citrome, L; Weiss-Citrome, A | 2 |
| Langley, P; Nalamachu, S; Pergolizzi, JV; Raffa, RB; Rodriguez, G; Taylor, R | 1 |
| Gordin, VN; Lamberg, JJ | 1 |
16 review(s) available for duloxetine hydrochloride and Pain, Chronic
| Article | Year |
|---|---|
Role of vortioxetine in the treatment of neuropathic pain.
Topics: Antidepressive Agents; Chronic Pain; Duloxetine Hydrochloride; Humans; Neuralgia; Vortioxetine | 2022 |
Antidepressants for pain management in adults with chronic pain: a network meta-analysis.
Topics: Adult; Antidepressive Agents; Chronic Pain; Duloxetine Hydrochloride; Humans; Milnacipran; Network Meta-Analysis; Pain Management; Randomized Controlled Trials as Topic | 2023 |
Efficacy and safety of duloxetine in chronic musculoskeletal pain: a systematic review and meta-analysis.
Topics: Analgesics; Antidepressive Agents; Chronic Pain; Duloxetine Hydrochloride; Humans; Musculoskeletal Pain | 2023 |
Efficacy and safety of duloxetine in osteoarthritis or chronic low back pain: a Systematic review and meta-analysis.
Topics: Analgesics; Chronic Pain; Duloxetine Hydrochloride; Humans; Low Back Pain; Osteoarthritis; Treatment Outcome | 2020 |
Pain in Parkinson's disease: new concepts in pathogenesis and treatment.
Topics: Analgesics; Botulinum Toxins; Chronic Pain; Deep Brain Stimulation; Duloxetine Hydrochloride; Humans; Naloxone; Oxycodone; Pain Management; Parkinson Disease | 2019 |
Efficacy of duloxetine versus alternative oral therapies: an indirect comparison of randomised clinical trials in chronic low back pain.
Topics: Administration, Oral; Analgesics; Chronic Pain; Duloxetine Hydrochloride; Humans; Low Back Pain; Randomized Controlled Trials as Topic; Thiophenes | 2013 |
Transient receptor potential ion channels: powerful regulators of cell function.
Topics: Analgesics; Anti-Inflammatory Agents; Biomarkers; Calcium Channels; Capsaicin; Chronic Pain; Duloxetine Hydrochloride; Humans; Inflammation; Macrophages; Melanoma; Monocytes; Nerve Tissue Proteins; Pain, Postoperative; Respiratory Tract Diseases; Surgical Wound Infection; Thiophenes; Transient Receptor Potential Channels; TRPA1 Cation Channel; TRPV Cation Channels | 2014 |
Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia.
Topics: Adult; Analgesics; Chronic Pain; Diabetic Neuropathies; Duloxetine Hydrochloride; Fibromyalgia; Humans; Neuralgia; Randomized Controlled Trials as Topic; Thiophenes | 2014 |
The noradrenergic locus coeruleus as a chronic pain generator.
Topics: Animals; Antidepressive Agents, Tricyclic; Chronic Pain; Duloxetine Hydrochloride; Humans; Locus Coeruleus; Norepinephrine; Serotonin and Noradrenaline Reuptake Inhibitors | 2017 |
[Desvenlafaxine and neuropathic pain: additional clinical benefits of a second generation serotonin-noradrenaline reuptake inhibitor].
Topics: Antidepressive Agents; Biological Availability; Biotransformation; Chronic Pain; Clinical Trials as Topic; Cytochrome P-450 Enzyme System; Depressive Disorder; Desvenlafaxine Succinate; Dose-Response Relationship, Drug; Drug Interactions; Duloxetine Hydrochloride; Humans; Multicenter Studies as Topic; Neuralgia; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2017 |
Case scenario: opioid association with serotonin syndrome: implications to the practitioners.
Topics: Analgesics, Opioid; Antidepressive Agents, Tricyclic; Celecoxib; Chronic Pain; Cyclooxygenase 2 Inhibitors; Depressive Disorder; Desipramine; Drug Interactions; Duloxetine Hydrochloride; Fentanyl; Humans; Male; Methadone; Middle Aged; Oxycodone; Polypharmacy; Pyrazoles; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Sulfonamides; Thiophenes; Transdermal Patch | 2011 |
Pharmacotherapy of fibromyalgia.
Topics: Analgesics; Chronic Pain; Clinical Trials as Topic; Cognition Disorders; Cyclopropanes; Duloxetine Hydrochloride; Fatigue; Fibromyalgia; gamma-Aminobutyric Acid; Humans; Milnacipran; Mood Disorders; Pain Management; Pregabalin; Selective Serotonin Reuptake Inhibitors; Sleep Wake Disorders; Syndrome; Thiophenes; Treatment Outcome | 2011 |
Fibromyalgia and sleep.
Topics: Analgesics; Central Nervous System Sensitization; Chronic Pain; Cyclopropanes; Duloxetine Hydrochloride; Fibromyalgia; gamma-Aminobutyric Acid; Humans; Milnacipran; Physical Therapy Modalities; Polysomnography; Pregabalin; Selective Serotonin Reuptake Inhibitors; Sleep; Sleep Wake Disorders; Syndrome; Thiophenes | 2011 |
Clinically relevant outcomes based on analysis of pooled data from 2 trials of duloxetine in patients with knee osteoarthritis.
Topics: Adrenergic Uptake Inhibitors; Aged; Chronic Pain; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Osteoarthritis, Knee; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Thiophenes; Treatment Outcome | 2012 |
A systematic review of duloxetine for osteoarthritic pain: what is the number needed to treat, number needed to harm, and likelihood to be helped or harmed?
Topics: Chronic Pain; Duloxetine Hydrochloride; Humans; Musculoskeletal Pain; Osteoarthritis; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Thiophenes | 2012 |
A review of duloxetine 60 mg once-daily dosing for the management of diabetic peripheral neuropathic pain, fibromyalgia, and chronic musculoskeletal pain due to chronic osteoarthritis pain and low back pain.
Topics: Analgesics; Chronic Pain; Diabetic Neuropathies; Duloxetine Hydrochloride; Fibromyalgia; Humans; Low Back Pain; Musculoskeletal Pain; Osteoarthritis; Thiophenes | 2013 |
23 trial(s) available for duloxetine hydrochloride and Pain, Chronic
| Article | Year |
|---|---|
No Added Value of Duloxetine in Patients With Chronic Pain due to Hip or Knee Osteoarthritis: A Cluster-Randomized Trial.
Topics: Chronic Pain; Duloxetine Hydrochloride; Humans; Knee Joint; Osteoarthritis, Hip; Osteoarthritis, Knee; Treatment Outcome | 2022 |
Duloxetine in OsteoArthritis (DOA) study: effects of duloxetine on pain and function in end-stage hip and knee OA - a pragmatic enriched randomized controlled trial.
Topics: Chronic Pain; Duloxetine Hydrochloride; Humans; Osteoarthritis, Hip; Osteoarthritis, Knee; Treatment Outcome | 2022 |
The effect of duloxetine on mechanistic pain profiles, cognitive factors and clinical pain in patients with painful knee osteoarthritis-A randomized, double-blind, placebo-controlled, crossover study.
Topics: Analgesics; Chronic Pain; Cognition; Cross-Over Studies; Double-Blind Method; Duloxetine Hydrochloride; Humans; Osteoarthritis, Knee; Treatment Outcome | 2022 |
An Interventional Response Phenotyping Study in Chronic Low Back Pain: Protocol for a Mechanistic Randomized Controlled Trial.
Topics: Chronic Pain; Duloxetine Hydrochloride; Humans; Low Back Pain; Physical Therapy Modalities; Randomized Controlled Trials as Topic; Research Design; Treatment Outcome | 2023 |
The Clinical Relevance of Pain Severity Changes: Is There Any Difference Between Asian and Caucasian Patients With Osteoarthritis Pain?
Topics: Adult; Aged; Analgesics; Asian People; Chronic Pain; Double-Blind Method; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Osteoarthritis; Pain Measurement; Severity of Illness Index; Treatment Outcome; White People | 2020 |
Predictors of duloxetine response in patients with neuropathic cancer pain: a secondary analysis of a randomized controlled trial-JORTC-PAL08 (DIRECT) study.
Topics: Adult; Aged; Cancer Pain; Chronic Pain; Double-Blind Method; Duloxetine Hydrochloride; Female; Humans; Japan; Male; Middle Aged; Neoplasms; Neuralgia; Pain Measurement; Placebos; Prognosis; Treatment Outcome | 2020 |
Efficacy of duloxetine in patients with knee osteoarthritis or chronic low back pain with early pain reduction: An exploratory post-hoc analysis of Japanese phase 3, 1-year extension studies.
Topics: Chronic Pain; Double-Blind Method; Duloxetine Hydrochloride; Humans; Japan; Low Back Pain; Osteoarthritis, Knee; Pain Measurement; Quality of Life; Treatment Outcome | 2022 |
Imaging pain relief in osteoarthritis (IPRO): protocol of a double-blind randomised controlled mechanistic study assessing pain relief and prediction of duloxetine treatment outcome.
Topics: Adult; Aged; Brain; Chronic Pain; Cross-Over Studies; Double-Blind Method; Duloxetine Hydrochloride; Female; Functional Neuroimaging; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Osteoarthritis, Knee; Pain Management; Pain Measurement; Quality of Life; Research Design; Surveys and Questionnaires; Treatment Outcome; United Kingdom | 2017 |
Effectiveness and cost-effectiveness of duloxetine added to usual care for patients with chronic pain due to hip or knee osteoarthritis: protocol of a pragmatic open-label cluster randomised trial (the DUO trial).
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents; Chronic Pain; Cost-Benefit Analysis; Duloxetine Hydrochloride; Female; Hip; Hip Joint; Humans; Joints; Knee; Knee Joint; Male; Musculoskeletal Pain; Osteoarthritis, Hip; Osteoarthritis, Knee; Pain Management; Quality of Life; Research Design; Treatment Outcome | 2017 |
Study protocol for a randomised, double-blind, placebo-controlled clinical trial of duloxetine for the treatment and prevention of musculoskeletal pain: altering the transition from acute to chronic pain (ATTAC pain).
Topics: Acute Pain; Adult; Chronic Pain; Double-Blind Method; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Musculoskeletal Pain; Pain Management; Pain Measurement; Serotonin and Noradrenaline Reuptake Inhibitors; Treatment Outcome | 2019 |
An Open-Label, 52-Week, Phase III Trial of Duloxetine in Japanese Patients with Chronic Low Back Pain.
Topics: Adult; Aged; Analgesics; Chronic Pain; Constipation; Duloxetine Hydrochloride; Female; Humans; Japan; Low Back Pain; Male; Middle Aged; Nausea; Pain Measurement; Sleepiness; Triethylenemelamine; Xerostomia | 2019 |
Comparing duloxetine and pregabalin for treatment of pain and depression in women with fibromyalgia: an open-label randomized clinical trial.
Topics: Adult; Chronic Pain; Depression; Drug Administration Schedule; Duloxetine Hydrochloride; Female; Fibromyalgia; Humans; Medication Adherence; Middle Aged; Pregabalin; Treatment Outcome; Young Adult | 2019 |
Maintenance of effect of duloxetine in Chinese patients with pain due to osteoarthritis: 13-week open-label extension data.
Topics: Aged; Analgesics; Arthralgia; Chronic Pain; Double-Blind Method; Drug Administration Schedule; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Osteoarthritis, Hip; Osteoarthritis, Knee; Pain Measurement; Treatment Outcome | 2019 |
Efficacy and safety of duloxetine versus placebo in adolescents with juvenile fibromyalgia: results from a randomized controlled trial.
Topics: Adolescent; Analgesics; Analysis of Variance; Chronic Pain; Double-Blind Method; Drug Administration Schedule; Duloxetine Hydrochloride; Female; Fibromyalgia; Humans; Male; Pain Measurement; Prospective Studies; Serotonin and Noradrenaline Reuptake Inhibitors | 2019 |
Comparison of safety outcomes among Caucasian, Hispanic, Black, and Asian patients in duloxetine studies of chronic painful conditions.
Topics: Adolescent; Adult; Analgesics; Asian; Black or African American; Chronic Pain; Duloxetine Hydrochloride; Female; Hispanic or Latino; Humans; Male; Middle Aged; Thiophenes; White People | 2013 |
Effectiveness and cost-effectiveness of transmural collaborative care with consultation letter (TCCCL) and duloxetine for major depressive disorder (MDD) and (sub)chronic pain in collaboration with primary care: design of a randomized placebo-controlled m
Topics: Adaptation, Psychological; Antidepressive Agents; Chronic Pain; Cost-Benefit Analysis; Depressive Disorder, Major; Double-Blind Method; Duloxetine Hydrochloride; Humans; Patient Care Team; Primary Health Care; Quality of Life; Referral and Consultation; Research Design; Self Care; Thiophenes | 2013 |
Duloxetine use in chronic painful conditions--individual patient data responder analysis.
Topics: Antidepressive Agents; Chronic Pain; Diabetic Neuropathies; Double-Blind Method; Duloxetine Hydrochloride; Fibromyalgia; Humans; Individuality; Low Back Pain; Osteoarthritis; Pain Measurement; Thiophenes; Treatment Outcome | 2014 |
Onset of response with duloxetine treatment in patients with osteoarthritis knee pain and chronic low back pain: a post hoc analysis of placebo-controlled trials.
Topics: Analgesics; Chronic Pain; Double-Blind Method; Drug Administration Schedule; Duloxetine Hydrochloride; Female; Humans; Low Back Pain; Male; Osteoarthritis, Knee; Pain Measurement | 2014 |
Randomized, Double-blind, Placebo-controlled Phase III Trial of Duloxetine Monotherapy in Japanese Patients With Chronic Low Back Pain.
Topics: Adult; Aged; Aged, 80 and over; Chronic Pain; Double-Blind Method; Duloxetine Hydrochloride; Female; Fibromyalgia; Humans; Japan; Low Back Pain; Male; Middle Aged; Pain Measurement; Placebos; Time Factors; Treatment Outcome; Young Adult | 2016 |
Efficacy and safety of duloxetine in Chinese patients with chronic pain due to osteoarthritis: a randomized, double-blind, placebo-controlled study.
Topics: Aged; Analgesics; Asian People; Chronic Pain; Double-Blind Method; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Osteoarthritis, Hip; Osteoarthritis, Knee; Treatment Outcome | 2017 |
Clinical study of duloxetine hydrochloride combined with doxazosin for the treatment of pain disorder in chronic prostatitis/chronic pelvic pain syndrome: An observational study.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Aged; Chronic Pain; Doxazosin; Duloxetine Hydrochloride; Humans; Male; Middle Aged; Pelvic Pain; Prospective Studies; Prostatitis; Serotonin and Noradrenaline Reuptake Inhibitors; Severity of Illness Index; Surveys and Questionnaires; Syndrome; Young Adult | 2017 |
Attributes of response in depressed patients switched to treatment with duloxetine.
Topics: Adult; Affective Symptoms; Antidepressive Agents; Chronic Pain; Depressive Disorder, Major; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Thiophenes; Treatment Outcome | 2011 |
Pilot study of duloxetine for treatment of aromatase inhibitor-associated musculoskeletal symptoms.
Topics: Adult; Aged; Aromatase Inhibitors; Chronic Pain; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Musculoskeletal Diseases; Pain; Pilot Projects; Postmenopause; Selective Serotonin Reuptake Inhibitors; Thiophenes | 2011 |
29 other study(ies) available for duloxetine hydrochloride and Pain, Chronic
| Article | Year |
|---|---|
Monoamine control of descending pain modulation after mild traumatic brain injury.
Topics: Amines; Animals; Brain Concussion; Brain Injuries, Traumatic; Chronic Pain; Duloxetine Hydrochloride; Female; Male; Mice; Norepinephrine; Ondansetron; Reboxetine; Receptors, Adrenergic; Selective Serotonin Reuptake Inhibitors; Serotonin | 2022 |
Comparison of efficacy and safety in the combination therapies of duloxetine and S-flurbiprofen plaster, and of duloxetine and conventional NSAIDs for chronic pain in patients with osteoarthritis (OASIS DUAL study).
Topics: Anti-Inflammatory Agents, Non-Steroidal; Chronic Pain; Drug-Related Side Effects and Adverse Reactions; Duloxetine Hydrochloride; Female; Flurbiprofen; Humans; Male; Osteoarthritis; Treatment Outcome | 2022 |
Tolerability and efficacy of duloxetine for the prevention of persistent musculoskeletal pain after trauma and injury: a pilot three-group randomized controlled trial.
Topics: Acute Pain; Adult; Chronic Pain; Double-Blind Method; Duloxetine Hydrochloride; Humans; Musculoskeletal Pain; Randomized Controlled Trials as Topic; Treatment Outcome | 2023 |
Fibromyalgia: Diagnosis and Management.
Topics: Analgesics; Chronic Pain; Duloxetine Hydrochloride; Female; Fibromyalgia; Humans; Pregabalin | 2023 |
[Medical Treatment of Chronic Pain].
Topics: Analgesics; Chronic Pain; Diabetic Neuropathies; Duloxetine Hydrochloride; Gabapentin; Humans; Pregabalin | 2023 |
Duloxetine, Gabapentin, and the Risk for Acute Myocardial Infarction, Stroke, and Out-of-Hospital Death in Medicare Beneficiaries With Non-Cancer Pain.
Topics: Aged; Chronic Pain; Duloxetine Hydrochloride; Gabapentin; Hospitals; Humans; Medicare; Myocardial Infarction; Retrospective Studies; Stroke; United States | 2023 |
Electroacupuncture attenuates chronic inflammatory pain and depression comorbidity by inhibiting hippocampal neuronal apoptosis via the PI3K/Akt signaling pathway.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Chronic Pain; Comorbidity; Depression; Duloxetine Hydrochloride; Electroacupuncture; Hippocampus; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Signal Transduction | 2023 |
Chronic Pain Syndromes: Fibromyalgia.
Topics: Chronic Pain; Duloxetine Hydrochloride; Fatigue; Female; Fibromyalgia; Humans; Male; Milnacipran; Pregabalin | 2023 |
Duloxetine ameliorates the impairment of diffuse noxious inhibitory control in rat models of peripheral neuropathic pain and knee osteoarthritis pain.
Topics: Analgesics; Animals; Chronic Pain; Diffuse Noxious Inhibitory Control; Duloxetine Hydrochloride; Male; Neuralgia; Osteoarthritis, Knee; Pain Measurement; Pregabalin; Rats, Sprague-Dawley | 2020 |
Loss of diffuse noxious inhibitory control after traumatic brain injury in rats: A chronic issue.
Topics: 5,7-Dihydroxytryptamine; Adrenergic Uptake Inhibitors; Animals; Brain Injuries, Traumatic; Capsaicin; Chronic Pain; Diffuse Noxious Inhibitory Control; Duloxetine Hydrochloride; Male; Neural Pathways; Norepinephrine; Pain Measurement; Rats; Rats, Sprague-Dawley; Reboxetine; Receptors, Adrenergic, alpha-2; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Agents | 2020 |
Reduction in anxiety during treatment with exercise and duloxetine is related to improvement of low back pain-related disability in patients with non-specific chronic low back pain.
Topics: Adult; Aged; Anxiety; Chronic Pain; Combined Modality Therapy; Disabled Persons; Duloxetine Hydrochloride; Exercise Therapy; Female; Humans; Low Back Pain; Male; Middle Aged; Prospective Studies | 2020 |
Diet and companionship modulate pain via a serotonergic mechanism.
Topics: Analgesics, Opioid; Anemia, Sickle Cell; Animals; Chronic Pain; Diet; Disease Models, Animal; Duloxetine Hydrochloride; Female; Fenclonine; Hyperalgesia; Interpersonal Relations; Male; Mice; Mice, Transgenic; Morphine; Serotonin; Serotonin and Noradrenaline Reuptake Inhibitors; Serotonin Antagonists; Signal Transduction; Spinal Cord | 2021 |
Chronic Pain Produces Reversible Memory Deficits That Depend on Task Difficulty in Rats.
Topics: Animals; Chronic Pain; Cognitive Dysfunction; Disease Models, Animal; Duloxetine Hydrochloride; Male; Neuralgia; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Recognition, Psychology; Serotonin and Noradrenaline Reuptake Inhibitors | 2021 |
Therapeutic effects of diclofenac, pregabalin, and duloxetine on disuse-induced chronic musculoskeletal pain in rats.
Topics: Animals; Chronic Pain; Diclofenac; Disease Models, Animal; Duloxetine Hydrochloride; Humans; Muscle, Skeletal; Muscular Disorders, Atrophic; Musculoskeletal Pain; Pain Measurement; Pain Threshold; Pregabalin; Rats; Rats, Sprague-Dawley | 2018 |
Duloxetine Improves Spinal Cord Stimulation Outcomes for Chronic Pain.
Topics: Adult; Aged; Analgesics; Analysis of Variance; Chronic Pain; Disability Evaluation; Dose-Response Relationship, Drug; Duloxetine Hydrochloride; Female; Follow-Up Studies; Humans; Male; Middle Aged; Pain Measurement; Psychiatric Status Rating Scales; Regression Analysis; Spinal Cord Stimulation; Treatment Outcome | 2019 |
[With the Characteristics of Chronic Pain Patients, Can the Therapeutic Effect of Antidepressant Duloxetine be Predicted?].
Topics: Adult; Aged; Antidepressive Agents; Anxiety; Chronic Pain; Depressive Disorder, Major; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Retrospective Studies | 2016 |
Cost-utility analysis of duloxetine in osteoarthritis: a US private payer perspective.
Topics: Adult; Aged; Aged, 80 and over; Analgesics; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Chronic Pain; Cost-Benefit Analysis; Duloxetine Hydrochloride; Female; Humans; Male; Markov Chains; Middle Aged; Models, Economic; Osteoarthritis; Prescription Fees; Thiophenes; United States | 2013 |
[Duloxetine for chronic pain management: pharmacology and clinical use].
Topics: Adrenergic Uptake Inhibitors; Chronic Pain; Depression; Depressive Disorder; Diabetic Neuropathies; Duloxetine Hydrochloride; Humans; Thiophenes | 2013 |
ACP Journal Club. Review: In neuropathy, fibromyalgia, or chronic pain, duloxetine reduces pain but increases adverse events.
Topics: Analgesics; Chronic Pain; Diabetic Neuropathies; Duloxetine Hydrochloride; Fibromyalgia; Humans; Neuralgia; Thiophenes | 2014 |
Pain management discussion forum: serious interaction among frequently used drugs for chronic pain.
Topics: Analgesics; Analgesics, Opioid; Chronic Pain; Dose-Response Relationship, Drug; Drug Interactions; Duloxetine Hydrochloride; Female; Humans; Middle Aged; Serotonin Syndrome; Thiophenes; Tramadol | 2014 |
Relationship between serotonin transporter occupancies and analgesic effects of AS1069562, the (+)-isomer of indeloxazine, and duloxetine in reserpine-induced myalgia rats.
Topics: Analgesics; Animals; Brain; Chronic Pain; Disease Models, Animal; Dose-Response Relationship, Drug; Duloxetine Hydrochloride; Hyperalgesia; Male; Morpholines; Myalgia; Pain Threshold; Pressure; Rats, Sprague-Dawley; Reserpine; Serotonin Plasma Membrane Transport Proteins; Treatment Outcome | 2015 |
Effect of spinal monoaminergic neuronal system dysfunction on pain threshold in rats, and the analgesic effect of serotonin and norepinephrine reuptake inhibitors.
Topics: Administration, Cutaneous; Analgesics; Animals; Biogenic Monoamines; Brain; Chronic Pain; Cyclopropanes; Duloxetine Hydrochloride; Injections, Spinal; Milnacipran; Neurons; Norepinephrine; Pain Threshold; Rats, Sprague-Dawley; Reserpine; Serotonin; Serotonin and Noradrenaline Reuptake Inhibitors; Spinal Cord; Vesicular Monoamine Transport Proteins | 2016 |
Questions Regarding "Efficacy of Duloxetine in Chronic Low Back Pain with a Neuropathic Component".
Topics: Analgesics; Chronic Pain; Duloxetine Hydrochloride; Humans; Low Back Pain; Neuralgia; Pain Measurement; Peripheral Nervous System Diseases; Thiophenes | 2016 |
Attentional performance may help to identify duloxetine responders in chronic pain fibromyalgia patients.
Topics: Adult; Aged; Attention; Chronic Pain; Duloxetine Hydrochloride; Female; Fibromyalgia; Humans; Middle Aged; Neuropsychological Tests; Pain Measurement; Treatment Outcome | 2017 |
Severe Venlafaxine Withdrawal Successfully Treated With a Short Course of Duloxetine.
Topics: Adult; Analgesics; Chronic Pain; Duloxetine Hydrochloride; Female; Humans; Low Back Pain; Neck Pain; Serotonin and Noradrenaline Reuptake Inhibitors; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride | 2017 |
Comparative effectiveness in pain-related outcomes and health care utilizations between veterans with major depressive disorder treated with duloxetine and other antidepressants: a retrospective propensity score-matched comparison.
Topics: Adolescent; Adult; Aged; Analgesics; Antidepressive Agents; Chronic Pain; Cohort Studies; Depressive Disorder, Major; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Pain Measurement; Retrospective Studies; Thiophenes; Veterans; Young Adult | 2012 |
Does pain improve earlier than mood in depressed patients with painful physical symptoms treated with duloxetine?
Topics: Adult; Affect; Antidepressive Agents; Chronic Pain; Depressive Disorder; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Pain Measurement; Prospective Studies; Surveys and Questionnaires; Thiophenes; Time Factors | 2012 |
Antidepressants and the relief of osteoarthritic pain - findings from a study examining adjunctive duloxetine.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents; Chronic Pain; Drug Combinations; Duloxetine Hydrochloride; Humans; Musculoskeletal Pain; Osteoarthritis; Thiophenes; Treatment Outcome | 2012 |
Serotonin syndrome in a patient with chronic pain polypharmacy.
Topics: Adult; Amitriptyline; Anti-Allergic Agents; Antidepressive Agents; Carisoprodol; Cetirizine; Chronic Pain; Duloxetine Hydrochloride; Female; Humans; Muscle Relaxants, Central; Narcotics; Polypharmacy; Serotonin Syndrome; Thiophenes; Tramadol | 2014 |